A Study of Olomorasib (LY3537982) in Healthy Japanese Participants
Clinical trial NCT07124013 · COMPLETED
Trial details
- NCT number
- NCT07124013
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-16
- Primary completion
- 2026-01-05
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.